Tag:
Aspen Pharmacare
Latest Headlines
Latest Headlines
Aspen Pharmacare eyes another $800M in M&A
South Africa's Aspen Pharmacare has posted some strong full-year sales and profits growth, thanks in part to expansion outside its home market. Part of that growth came from its $879 million
India's Indoco signs on to make meds for Aspen
India's Indoco Remedies inked a deal to supply generic products to South Africa's Aspen Pharmacare for sale in the Australian market. Aspen bought Australia-based Sigma Pharmaceuticals' generics
S. Africa mulls state-run pharma to control HIV med costs
South Africa has decided to take HIV drug pricing into its own hands. After years of complaining that the cost of AIDS drugs was too high, the government says it will start a state-run drug company
Big pharma pounces on South Africa
Drugmakers stand at the ready as South Africa pulls out of recession. Ranbaxy Laboratories has opened its second manufacturing plant there, a $30-million facility called the Be-Tabs Pharmaceuticals
Aspen nabs Sigma's drug biz for $804M
Sigma Pharmaceuticals was playing its cards close to the vest last week when it denied a higher buyout offer from South Africa's Aspen Pharmacare. Aspen might not have hiked its offer for the entire
Sigma denies sweetened buyout bid from Aspen
Sigma Pharmaceuticals denied Australian media reports that Aspen Pharmacare Holdings had boosted its buyout offer for the company to 65 cents per share, or $689 million; Aspen's formal bid made last
Report: Watson flirts with Sigma offer
Sigma Pharmaceuticals is reportedly getting a new suitor. The Australian drugmaker has caught the eye of U.S.-based Watson Pharmaceuticals, which is working to expand its presence overseas. Watson
With Aspen circling, Sigma gets piecemeal bids
Australia's Sigma Pharmaceuticals ( SIP.AX ) has received three bids for its Herron drugs arm and three bids for its Orphan Australia drugs business, as it seeks an improved bid for the entire company
Aspen drops Sigma bid by 8 percent
As analysts predicted, Aspen Pharmacare cut its buyout offer for Sigma Pharmaceuticals--to $552 million, an 8 percent drop--raising questions about whether a deal might actually happen. Report
Aspen likely to cut $596M offer for Sigma
Now that Aspen Pharmacare has had a look at Sigma Pharmaceuticals' books, it's not as enamored with the Australian drugmaker. Sources tell Bloomberg that Aspen now plans to reduce its A$707 million
